These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 83274)

  • 21. Kinetic aspects of the interaction of blood clotting enzymes. 3. Demonstration of an inhibitor of prothrombin conversion in vitamin K deficiency.
    Hemker HC; Veltkamp JJ; Loeliger EA
    Thromb Diath Haemorrh; 1968 Jul; 19(3):346-63. PubMed ID: 4179187
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition rather than enhancement of hemostatic system activation during initiation of oral anticoagulant treatment.
    Kyrle PA; Brockmeier J; Weltermann A; Eichinger S; Speiser W; Lechner K; Eichler HG
    Thromb Haemost; 1997 Apr; 77(4):685-9. PubMed ID: 9134643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term anticoagulation: the prospects for alternatives to warfarin.
    Ansell J
    Semin Vasc Surg; 2005 Sep; 18(3):134-8. PubMed ID: 16168888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of combined antenatal vitamin K and phenobarbital therapy on umbilical blood coagulation studies in infants less than 34 weeks' gestation.
    Thorp JA; Caspers DR; Cohen GR; Zucker ML; Strope BD; McKenzie DR
    Obstet Gynecol; 1995 Dec; 86(6):982-9. PubMed ID: 7501353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased activity of vitamin K-dependent clotting factors in human hyperlipoproteinaemia - association with cholesterol and triglyceride levels.
    Constantino M; Merskey C; Kudzma DJ; Zucker MB
    Thromb Haemost; 1977 Aug; 38(2):465-74. PubMed ID: 579489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human monocytes have prothrombin cleaving activity.
    Hogg N
    Clin Exp Immunol; 1983 Sep; 53(3):725-30. PubMed ID: 6352100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin K-dependent multifactor coagulopathy in Devon Rex cats.
    Maddison JE; Watson AD; Eade IG; Exner T
    J Am Vet Med Assoc; 1990 Dec; 197(11):1495-7. PubMed ID: 2272883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vitamin K dependent blood clotting proteins (author's transl)].
    Kopeć M
    Postepy Biochem; 1980; 26(1):3-28. PubMed ID: 6994082
    [No Abstract]   [Full Text] [Related]  

  • 29. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
    Saito H; Ratnoff OD
    J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of action of anticoagulants: correlation between the inhibition of prothrombin synthesis and the regeneration of vitamin K1 from vitamin K1 epoxide.
    Ren P; Stark PY; Johnson RL; Bell RG
    J Pharmacol Exp Ther; 1977 Jun; 201(3):541-6. PubMed ID: 864593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [-Anticoagulant drugs-].
    Gulba DC
    Herz; 1996 Feb; 21(1):12-27. PubMed ID: 8647576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical vitamin K deficiency in early infancy: diagnostic limitation of conventional coagulation tests.
    Widdershoven J; Kollée L; van Munster P; Bosman AM; Monnens L
    Helv Paediatr Acta; 1986 Aug; 41(3):195-201. PubMed ID: 3759482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decrease of normotest/thrombotest discrepancy in non-contacted coumarin plasma after glass or ellagic acid activation.
    Girolami A; Patrassi G; Burul A
    Blut; 1976 Jul; 33(1):41-8. PubMed ID: 974273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Christman-factor (factor IX) deficiency produced by concurrent administration of heparin with coumarin drugs.
    GREIG HB
    Lancet; 1959 Jul; 2(7089):25-6. PubMed ID: 13673578
    [No Abstract]   [Full Text] [Related]  

  • 35. The Christmas factor deficiency in coumarin therapy.
    DOUGLAS AS; MAIR K
    Clin Sci; 1958 Aug; 17(3):445-55. PubMed ID: 13585654
    [No Abstract]   [Full Text] [Related]  

  • 36. Factor V assays in patients on coumarin therapy, or with vitamin K deficiency.
    Macheta AT; Craig S; Fisher AH; Taberner DA
    Clin Lab Haematol; 1987; 9(4):429. PubMed ID: 3442978
    [No Abstract]   [Full Text] [Related]  

  • 37. Comments on the significance of differences between thrombotest and normotest in the study of coumarin plasma.
    Girolami A
    Haemostasis; 1989; 19(4):241-4. PubMed ID: 2807042
    [No Abstract]   [Full Text] [Related]  

  • 38. [On the use of dicumarin as a means of preventing blood clotting in some animal experiences].
    de la BARREDA P; FERNANDEZ DE MOLINA A; GRANDE COVIAN F
    Rev Clin Esp; 1947 Apr; 25(1):47. PubMed ID: 20260027
    [No Abstract]   [Full Text] [Related]  

  • 39. Evidence against the presence of "inhibitors" in coumarin treated patients.
    Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(4):523-9. PubMed ID: 83274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congenital bleeding disorders of the vitamin K-dependent clotting factors.
    Girolami A; Scandellari R; Scapin M; Vettore S
    Vitam Horm; 2008; 78():281-374. PubMed ID: 18374200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.